SE8702936L - Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar - Google Patents

Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar

Info

Publication number
SE8702936L
SE8702936L SE8702936A SE8702936A SE8702936L SE 8702936 L SE8702936 L SE 8702936L SE 8702936 A SE8702936 A SE 8702936A SE 8702936 A SE8702936 A SE 8702936A SE 8702936 L SE8702936 L SE 8702936L
Authority
SE
Sweden
Prior art keywords
tioethers
oxabicycloheptan
hydroximic acids
substituted ethers
hydroximic
Prior art date
Application number
SE8702936A
Other languages
English (en)
Other versions
SE8702936D0 (sv
Inventor
R K Varma
E M Gordon
L M Simpkins
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE8702936D0 publication Critical patent/SE8702936D0/sv
Publication of SE8702936L publication Critical patent/SE8702936L/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8702936A 1986-07-23 1987-07-22 Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar SE8702936L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/888,671 US4673685A (en) 1986-07-23 1986-07-23 Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Publications (2)

Publication Number Publication Date
SE8702936D0 SE8702936D0 (sv) 1987-07-22
SE8702936L true SE8702936L (sv) 1988-04-07

Family

ID=25393633

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702936A SE8702936L (sv) 1986-07-23 1987-07-22 Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar

Country Status (29)

Country Link
US (1) US4673685A (sv)
JP (1) JP2557894B2 (sv)
KR (1) KR950010596B1 (sv)
AT (1) AT397094B (sv)
AU (1) AU599384B2 (sv)
BE (1) BE1000141A3 (sv)
CA (1) CA1292003C (sv)
CH (1) CH674010A5 (sv)
DD (1) DD263990A5 (sv)
DE (1) DE3724152A1 (sv)
DK (1) DK383587A (sv)
ES (1) ES2006784A6 (sv)
FI (1) FI873207A (sv)
FR (1) FR2601953B1 (sv)
GB (1) GB2192882B (sv)
GR (1) GR871147B (sv)
HU (1) HU198495B (sv)
IE (1) IE60487B1 (sv)
IL (1) IL82919A0 (sv)
IT (1) IT1222054B (sv)
LU (1) LU86949A1 (sv)
NL (1) NL8701742A (sv)
NO (1) NO168359C (sv)
NZ (1) NZ220677A (sv)
PH (1) PH23711A (sv)
PT (1) PT85381B (sv)
SE (1) SE8702936L (sv)
YU (1) YU46321B (sv)
ZA (1) ZA874255B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8501035D0 (en) * 1985-01-16 1985-02-20 Senior J Prostaglandins
AU593316B2 (en) * 1986-02-14 1990-02-08 E.R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease
US4925873A (en) * 1988-09-01 1990-05-15 E. R. Squibb & Sons, Inc. Method of treating skin injuries using thromboxane A2 receptor antagonists
US5093329A (en) * 1990-03-12 1992-03-03 Allergan, Inc. Intraocular pressure reducing prostaglandin-like 7-oxabicyclo derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4242273A (en) * 1977-09-27 1980-12-30 American Cyanamid Company 4-(Monoalkylamino)benzoic acid amides and imidates
US4254044A (en) * 1977-11-04 1981-03-03 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane- and 7-oxabicycloheptene compounds
US4187236A (en) * 1977-11-04 1980-02-05 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane compounds
US4143054A (en) * 1977-11-04 1979-03-06 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane- and 7-oxabicycloheptene compounds
US4220594A (en) * 1977-11-04 1980-09-02 E. R. Squibb & Sons, Inc. Hexa- and octahydro-4,7-epoxyisobenzofuran-1-ol and hexa- and octahydro-5,8-epoxy-1H-2-benzopyran-3-ol
US4368332A (en) * 1979-01-05 1983-01-11 National Research Development Corporation Prostaglandins
US4440940A (en) * 1979-10-17 1984-04-03 American Cyanamid Company Anti-atherosclerotic agents
US4228180A (en) * 1979-11-01 1980-10-14 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane and 7-oxabicycloheptene prostaglandin analogs
ZA829068B (en) * 1980-07-01 1983-02-23 Nat Res Dev Prostaglandins
EP0082646B1 (en) * 1981-12-23 1989-11-15 National Research Development Corporation Prostaglandins
US4466979A (en) * 1983-01-21 1984-08-21 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted carbamate prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
CA1256887A (en) * 1983-03-14 1989-07-04 Steven E. Hall 7-oxabicycloheptane substituted prostaglandin analogs
US4474803A (en) * 1983-03-14 1984-10-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted thio prostaglandin analogs useful in treating platelet aggregation and bronchoconstriction
US4513103A (en) * 1983-10-21 1985-04-23 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane ethers useful in the treatment of thrombolytic disease
US4526901A (en) * 1984-01-26 1985-07-02 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted oxamide prostaglandin analogs and their use in treating thrombolytic disease
US4536513A (en) * 1984-03-14 1985-08-20 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful in the treatment of thrombolytic disease
US4661506A (en) * 1984-11-30 1987-04-28 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted ox prostaglandin analogs
US4654367A (en) * 1986-02-14 1987-03-31 E. R. Squibb & Sons, Inc. Hydroxamic acids of 7-oxabicycloheptane substituted ethers useful as anti-allergy and anti-inflammation agents
US4652578A (en) * 1986-02-24 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide prostaglandin analogs
US4673685A (en) * 1986-07-23 1987-06-16 E. R. Squibb & Sons, Inc. Hydroximic acids of 7-oxabicycloheptane substituted ethers and thioethers useful in the treatment of thrombotic disease

Also Published As

Publication number Publication date
ATA174887A (de) 1993-06-15
KR880001660A (ko) 1988-04-25
GR871147B (en) 1987-12-04
NO168359B (no) 1991-11-04
PH23711A (en) 1989-09-27
SE8702936D0 (sv) 1987-07-22
AT397094B (de) 1994-01-25
YU138187A (en) 1988-12-31
AU599384B2 (en) 1990-07-19
GB2192882B (en) 1990-05-09
CH674010A5 (sv) 1990-04-30
IT8721328A0 (it) 1987-07-16
KR950010596B1 (ko) 1995-09-20
IL82919A0 (en) 1987-12-20
ES2006784A6 (es) 1989-05-16
DK383587A (da) 1988-01-24
FI873207A0 (fi) 1987-07-21
FR2601953B1 (fr) 1990-11-16
YU46321B (sh) 1993-05-28
HU198495B (en) 1989-10-30
US4673685A (en) 1987-06-16
DE3724152A1 (de) 1988-02-04
DD263990A5 (de) 1989-01-18
NO168359C (no) 1992-02-12
FI873207A (fi) 1988-01-24
IT1222054B (it) 1990-08-31
GB8714621D0 (en) 1987-07-29
CA1292003C (en) 1991-11-12
FR2601953A1 (fr) 1988-01-29
AU7444887A (en) 1988-01-28
BE1000141A3 (fr) 1988-05-03
IE60487B1 (en) 1994-07-27
NZ220677A (en) 1989-12-21
HUT47115A (en) 1989-01-30
PT85381B (pt) 1990-04-30
LU86949A1 (fr) 1988-02-02
IE871675L (en) 1988-01-23
JP2557894B2 (ja) 1996-11-27
GB2192882A (en) 1988-01-27
NO873069L (no) 1988-01-25
JPS6335576A (ja) 1988-02-16
NL8701742A (nl) 1988-02-16
PT85381A (en) 1987-08-01
DK383587D0 (da) 1987-07-22
NO873069D0 (no) 1987-07-22
ZA874255B (en) 1988-02-24

Similar Documents

Publication Publication Date Title
AU565908B2 (en) 7-oxabicyclo 2.2.1 hept-2-yl-5 alkyl/alkenyl carboxylic acids
ES2008658A4 (es) Procedimiento de preparacion de monoesteres o diesteres del acido 9,10-dihidro antraceno-11,11-dicarboxilico.
ES477695A1 (es) Un procedimiento para preparar derivados de deshidrociclici-minoacidos.
DK436182A (da) Cyclovitamin-d forbindelser
SE7900952L (sv) Metronidazolfosfat och salter derav
FI822203A0 (fi) Nya 2-aryl-3,4-diaza-bicyklo/4,n,0/-alken-(2)-oner-(5), foerfarande foer deras framstaellning och dessa innehaollande laekemedel
SE7813352L (sv) Nya 2-pyrrolidonforeningar och forfarande for framstellning av desamma
SE8307146L (sv) 7-oxabicykloheptan-substituerade aminoprostaglandinanaloger
SE8405123D0 (sv) Forfarande for framstellning av pyrrolidin- eller pyridinkarboxylsyraderivat
SE8702936L (sv) Hydroximsyror av 7-oxabicykloheptansubstituerade etrar och tioetrar
ES545009A0 (es) Procedimiento de preparacion de nuevas fenil-naftiridinas.
AU562182B2 (en) Bicyclo(4,2,0)1,3,5-octatriene derivatives
AU8143487A (en) New derivatives of 2,2-dimethyl cyclopropane carboxylic acid having a saturated halogenated chain in position 3, the process and the intermediates for their preparation, their use as pesticides and the compositions containing them
JPS5227791A (en) Synthesis of cephalosporins
NO792126L (no) Karbazolderivater.
SE8803765D0 (sv) Nya isopolypeptider samt foerfarande foer framstaellning av desamma
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
SE8401280L (sv) Mellanprodukter och forfaraden for framstellning derav
ATE97657T1 (de) Verfahren zur herstellung von propionsaeurederivaten.
ES2060854T3 (es) Procedimiento para la preparacion de acido 2-mercapto-4-metil-1,3-tiazol-5-il-acetico y sus esteres.
SE8204791D0 (sv) Process for preparing alkoxy-vincaminic acid esters and alkoxy-apovincaminic acid esters
ES502947A0 (es) Procedimiento para la obtencion de esteres de acido dimeta- crilico
DE3662892D1 (en) Bisthiol phosphates, process for their preparation, their use as pesticides and agents therefor
FI821583A0 (fi) Nya 1-pyrrolintiolaktimetrar och foerfarande foer deras framstaellning
AU529684B2 (en) Organic compounds

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8702936-9

Effective date: 19920224